Status:
COMPLETED
SCREENING FOR THE IMPLANTATION OF A SUBCUTANEOUS IMPLANTABLE AUTOMATIC DEFIBRILLATOR
Lead Sponsor:
Centre Hospitalier de PAU
Conditions:
Sudden Cardiac Death
Implantable Defibrillator
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
S-ICD (subcutaneous implantable cardioverter-defibrillator) screening failure occurs in about 10% of cases. Predictors of screening failure are not yet well determined. Moreover, slight variations in ...
Detailed Description
S-ICD (subcutaneous implantable cardioverter-defibrillator) has become the last years widespread in various pathological conditions and implantation rates are increasing each year worldwide. Previous ...
Eligibility Criteria
Inclusion
- The population will be composed of all patients referred for ICD method, aged over 18 years
Exclusion
- Age \< 18 years old
- Patients who cannot freely give their consent, or patients who refuse to participate
Key Trial Info
Start Date :
December 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 14 2023
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT04101253
Start Date
December 16 2019
End Date
February 14 2023
Last Update
April 10 2023
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de BREST
Brest, France
2
CHU de Caen
Caen, France
3
CHRU de Lille
Lille, France
4
Hopital Saint Philivert
Lille, France